How many births a year in the US? According to th
Post# of 9122
How much does it cost to test for GBS? If positively ID'd, how much does it cost to determine antibiotic sensitivity?
According to Dr. Sebastian Faro, the N-Assay is cheap, simple, much faster, and far more accurate than any other assay currently available. I think it`s safe to assume that it will cost more than either the standard petri dish or the BNP. As an exercise to show how the market cap does not reflect the true value of the company, let's compute revenue if the N-Assay is sold:
At $10 each, revenue is $40million per year.
At $5 each, revenue is $20m per year.
Current market cap is $13m.
Don't forget the revenues that the flatpack and BNP will add as the company continues to grow it's share of the market. When the N-Assay launches commercially, I see fast adoption of it as the test of choice for GBS and any bacteria it works for.
It's only a matter of time. The company has a proven track record of delivering good progress under current management. Sure it has been late on some things and sure there have been changes along the way, but it has always delivered. Two great products have been brought to market and a third is on its way. I am certain that there will be news that will eventually break the hold that manipulators have on the share price. I would not be here if I didn't believe this. It's frustrating, but if you're still holding, you must feel the same or be insane.
The bashers feel it too. Why else would they be so strongly motivated to incessantly cultivate fear in current investors and drive off potential investors? They've thrown every trick in the book at subduing the retail market and have succeeded in large. It's a battle between them and the Company. Noone but the Company knows how sales of flatpack petri plates and BNP kits are going. Although it's difficult, I'd rather the Company kept the financials a secret until they were absolutely certain that releasing this info would break the backs of the bashers for good.
Bashers hope to starve the company before the Company can deliver the ultimate success to its shareholders -- fair value of the company, which I believe to be in the BILLIONS. Its a race and my money is on Nanologix and it's current management.